GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

glucose dependent insulinotropic polypeptide

Company
Hvidovre University Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
19 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

19 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for glucose dependent insulinotropic polypeptide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01851694

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

    Not yet reported University of Pennsylvania 45 participants Est. completion 2026-12 1 site
    Other conditions: Cystic Fibrosis, Pancreatic Insufficiency
    View official trial listing →
  • Recruiting NCT NCT05375968

    Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

    Not yet reported Vanderbilt University Medical Center 50 participants Est. completion 2028-06-01 1 site
    Other conditions: Postural Tachycardia Syndrome (POTS)
    View official trial listing →
  • Recruiting NCT NCT05662189

    Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

    Not yet reported Azienda Ospedaliero-Universitaria di Parma 70 participants Est. completion 2025-12 1 site
    Other conditions: Type1diabetes, Type2diabetes, Pre Diabetes, Hyperinsulinism
    View official trial listing →
  • Recruiting NCT NCT06191848

    Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

    Not yet reported University of Melbourne 352 participants Est. completion 2037-05 4 sites
    Osteoarthritis Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT06774079

    Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

    Not yet reported University of Miami 24 participants Est. completion 2027-03-05 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT06790225

    Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

    Not yet reported Esbjerg Hospital - University Hospital of Southern Denmark 12 participants Est. completion 2027-11-30 1 site
    Type 2 diabetes Other conditions: Bone Disease, Metabolic, Obesity and Obesity-related Medical Conditions
    View official trial listing →
  • Recruiting NCT NCT06934473

    Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

    Not yet reported University Hospital, Gentofte, Copenhagen 16 participants Est. completion 2026-01-31 2 sites
    Other conditions: Bloodpressure
    View official trial listing →
  • Recruiting NCT NCT06939088

    Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

    Not yet reported Anders Fink-Jensen, MD, DMSci 108 participants Est. completion 2028-12-31 2 sites
    Alcohol use disorder Other conditions: Alcohol Abuse/Dependence, Alcoholism, Schizophrenia Disorders, Schizophrenia and Disorders With Psychotic Features, Schizophrenia and Schizophrenia Spectrum Psychosis, Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT07019519

    POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

    Not yet reported University of Copenhagen 30 participants Est. completion 2026-09-30 1 site
    Other conditions: Postural Orthostatic Tachycardia Syndrome (POTS), Healthy
    View official trial listing →
  • Recruiting NCT NCT07169851

    A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

    Not yet reported Eli Lilly and Company 204 participants Est. completion 2027-02 68 sites
    Other conditions: Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07284875

    Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

    Not yet reported Kailera 2340 participants Est. completion 2028-03 104 sites
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Recruiting NCT NCT07284901

    Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

    Not yet reported Kailera 1156 participants Est. completion 2028-04-24 167 sites
    Other conditions: Obesity With Diabetes, Overweight With Diabetes
    View official trial listing →
  • Recruiting NCT NCT07284979

    Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

    Not yet reported Kailera 1200 participants Est. completion 2028-04 59 sites
    Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07373834

    Tirzepatide and Muscle Outcomes in Obesity

    Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2027-03 1 site
    Other conditions: Obesity (Disorder)
    View official trial listing →
  • Recruiting NCT NCT07398300

    Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

    Not yet reported Rigshospitalet, Denmark 36 participants Est. completion 2027-05 1 site
    Type 2 diabetes Other conditions: Healhty
    View official trial listing →
  • Recruiting NCT NCT07411560

    A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

    Not yet reported Novo Nordisk A/S 100 participants Est. completion 2027-01-26 1 site Stand-alone
    Other conditions: Overweight, Obese
    View official trial listing →
  • Recruiting NCT NCT07554638

    Incretin Therapies in Obesity-related HFpEF

    Not yet reported Columbia University 50 participants Est. completion 2030-04 1 site
    Heart failure Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07685808

    Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

    Not yet reported Regeneron Pharmaceuticals 360 participants Est. completion 2028-01-21 5 sites
    Other conditions: Overweight or Obesity
    View official trial listing →
  • Recruiting NCT NCT07740291

    Tirzepatide Impact Assessment Study

    Not yet reported Texas Tech University 27 participants Est. completion 2026-12-07 1 site
    Other conditions: Obesity & Overweight, Cardiometabolic Health Indicators, Addiction, Eating Disorders, Mental Health
    View official trial listing →
  • Completed NCT NCT00239707

    GIP: Glucose-dependent Insulinotropic Peptide

    Not yet reported National Institute on Aging (NIA) 41 participants Est. completion 2006-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00321321

    The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2007-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00488423

    Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

    Not yet reported The Cleveland Clinic 21 participants Est. completion 2008-11 1 site
    Other conditions: Diabetes, Gastric Bypass
    View official trial listing →
  • Completed NCT NCT00529048

    Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

    Herlev Hospital 16 participants Est. completion 2009-09 1 site
    Other conditions: Incretin Effect
    View official trial listing →
  • Completed NCT NCT00566189

    New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

    Not yet reported, Not yet reported University of Campinas, Brazil 36 participants Est. completion 2012-12 1 site
    Type 2 diabetes Other conditions: Insulin Resistance, Obesity
    View official trial listing →
  • Terminated NCT NCT00566215

    Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

    Not yet reported, Not yet reported University of Campinas, Brazil 6 participants Est. completion 2009-06 1 site
    Type 2 diabetes Other conditions: Insulin Resistance, Obesity
    View official trial listing →
  • Completed NCT NCT00566358

    Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

    Not yet reported, Not yet reported University of Campinas, Brazil 18 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00603031

    Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

    Not yet reported Hvidovre University Hospital 9 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Type-1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00612950

    Beta-Cell Function After Near-Normalisation of Blood Glucose

    Not yet reported Hvidovre University Hospital 8 participants Est. completion 2007-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00625040

    Incretin Physiology and Beta-cell Function Before and After Weight-loss

    Glostrup University Hospital, Copenhagen 10 participants Est. completion 2011-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00713440

    Incretin Physiology Associated With Steroid Hormone Treatment

    Not yet reported Glostrup University Hospital, Copenhagen 10 participants Est. completion 2009-01 1 site
    Type 2 diabetes Other conditions: Steroids
    View official trial listing →
  • Completed NCT NCT00716170

    GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

    Herlev Hospital 10 participants Est. completion 2009-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00732602

    The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 8 participants 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00774488

    Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose Tissue

    Not yet reported German Institute of Human Nutrition 17 participants Est. completion 2007-07
    Metabolic syndrome Other conditions: Obesity, Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT00798915

    Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus

    Not yet reported Washington University School of Medicine 40 participants Est. completion 2012-12 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT00809029

    The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study

    Not yet reported Liverpool University Hospitals NHS Foundation Trust 12 participants Est. completion 2012-12 1 site
    Other conditions: Adipose Tissue
    View official trial listing →
  • Completed NCT NCT00830076

    A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)

    Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2009-05-14
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00832741

    Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

    Hvidovre University Hospital 30 participants Est. completion 2008-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00834938

    Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

    University of Campinas, Brazil 24 participants Est. completion 2010-07 1 site
    Other conditions: Diabetes, Bariatric Surgery, Obesity
    View official trial listing →
  • Completed NCT NCT00843232

    Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

    University of Campinas, Brazil 24 participants Est. completion 2010-09 1 site
    Type 2 diabetes Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00843479

    The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly

    University of Campinas, Brazil 24 participants Est. completion 2010-09 1 site
    Type 2 diabetes Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00949663

    Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function

    Not yet reported Washington University School of Medicine 38 participants Est. completion 2014-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00975052

    A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 16 participants Est. completion 2006-03
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00999271

    Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

    Hvidovre University Hospital 30 participants Est. completion 2009-09 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01048268

    Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?

    Not yet reported, Not yet reported University Hospital, Gentofte, Copenhagen 30 participants Est. completion 2014-04 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01189890

    Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

    Not yet reported Merck Sharp & Dohme LLC 480 participants Est. completion 2012-10-31
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01274052

    Study of Postprandial Incretin Response in Women With Gestational Diabetes

    University Hospital, Gentofte, Copenhagen 19 participants Est. completion 2008-07 1 site
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01374568

    Changes in Bone Turnover With Increased Incretin Hormone Exposure

    Not yet reported University of Alabama at Birmingham 6 participants Est. completion 2015-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01375270

    Glucolipotoxicity and Type 2 Diabetes

    Not yet reported Rigshospitalet, Denmark 30 participants Est. completion 2014-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01414556

    GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes

    Not yet reported Mikkel Christensen 12 participants Est. completion 2012-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01698502

    Physical Training and the Incretin Effect

    University of Copenhagen 21 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01779622

    Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

    Not yet reported Lund University 24 participants Est. completion 2014-06 1 site
    Other conditions: Healthy Volunteers Recruited From the General Population
    View official trial listing →
  • Completed NCT NCT01880827

    Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery

    Not yet reported Turku University Hospital 36 participants Est. completion 2016-01 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01938469

    Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

    Not yet reported St. Luke's-Roosevelt Hospital Center 33 participants Est. completion 2014-07 1 site
    Other conditions: Gastric Bypass Surgery, Obesity
    View official trial listing →
  • Completed NCT NCT01975259

    Investigating the Incretin Effect in Cystic Fibrosis

    Liverpool Heart and Chest Hospital NHS Foundation Trust 50 participants Est. completion 2015-07 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT01999504

    Gut Hormone Response After Paleolithic-type Meals

    Not yet reported Unilever R&D 24 participants Est. completion 2014-10 1 site
    Other conditions: Insulin Resistance, Satiety
    View official trial listing →
  • Completed NCT NCT02235584

    Insulinotropic Effect of GLP-1 and GIP After Dexamethasone

    Not yet reported Hvidovre University Hospital 19 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02237521

    The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease

    Bo Feldt-Rasmussen 24 participants Est. completion 2016-04-28 1 site
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT02372526

    The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

    Kirstine Nyvold Bojsen-Moeller 18 participants Est. completion 2017-06 1 site
    Other conditions: Bariatric Surgery (Gastric Bypass), Overweight
    View official trial listing →
  • Completed NCT NCT02518737

    Examination of the Postprandial Bone Remodeling in Persons With Reduced GIP-Receptor Activity

    University of Copenhagen 36 participants Est. completion 2016-06 1 site
    Other conditions: Bone Remodeling
    View official trial listing →
  • Completed NCT NCT02589028

    The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones

    Not yet reported Seoul National University Hospital 30 participants Est. completion 2016-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02598791

    GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake

    Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2016-06-20 1 site
    Type 2 diabetes Other conditions: Obesity, Adiposity
    View official trial listing →
  • Completed NCT NCT02639130

    GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

    Not yet reported Diabeteszentrum Bad Lauterberg im Harz 67 participants Est. completion 2010-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02673554

    The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

    Not yet reported Diabeteszentrum Bad Lauterberg im Harz 30 participants
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02747472

    GIP Receptor Antagonist Studies in Humans

    Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2016-07 1 site
    Other conditions: Glucose Metabolism
    View official trial listing →
  • Completed NCT NCT03081676

    The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

    Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2018-06-01 1 site
    Other conditions: Maturity-Onset Diabetes of the Young, Type 3
    View official trial listing →
  • Completed NCT NCT03195257

    Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

    Not yet reported Mikkel Christensen 10 participants Est. completion 2016-12-01
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03556098

    Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes

    Not yet reported Steno Diabetes Center Copenhagen 12 participants Est. completion 2020-02-11 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03573934

    Gut Hormones and Bone Remodeling in Humans (KS-2)

    Not yet reported University of Copenhagen 10 participants Est. completion 2018-03-15 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03574064

    Effects of Gut Peptides on Bone Remodeling

    Not yet reported University of Copenhagen 10 participants Est. completion 2019-01-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03702660

    Effect of GIP After a Meal in Patients With Type 2 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2018-01-23 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03728959

    Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.

    Not yet reported University of Copenhagen 7 participants Est. completion 2019-04-12 1 site
    Other conditions: Hypoparathyroidism
    View official trial listing →
  • Completed NCT NCT03734718

    The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes

    Not yet reported Steno Diabetes Center Copenhagen 20 participants Est. completion 2019-12-31 1 site
    Other conditions: Diabetes Mellitus, Type 1, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT03770910

    The Effect of GIP(3-30)NH2

    Not yet reported University Hospital, Gentofte, Copenhagen 8 participants Est. completion 2019-12-01 2 sites
    Other conditions: Endocrine - Other
    View official trial listing →
  • Completed NCT NCT03807076

    Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

    Not yet reported University of Copenhagen 25 participants Est. completion 2023-11-28 1 site
    Other conditions: Acromegaly Due to Pituitary Adenoma
    View official trial listing →
  • Completed NCT NCT03829800

    Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes

    Not yet reported Universidad del Zulia 23 participants Est. completion 2018-11-15
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03845179

    GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

    Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2020-02-28 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03867656

    Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19

    Not yet reported University of Copenhagen 10 participants Est. completion 2020-06-26 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03919877

    Precision Diets for Diabetes Prevention

    Not yet reported Stanford University 115 participants Est. completion 2023-10-18 1 site
    Type 2 diabetes Other conditions: Pre Diabetes, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT03950245

    Incretin Hormone Antagonism After Bariatric Surgery

    Not yet reported Hvidovre University Hospital 36 participants Est. completion 2021-04-16 2 sites
    Other conditions: Bariatric Surgery
    View official trial listing →
  • Completed NCT NCT03954834

    A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

    Not yet reported Eli Lilly and Company 478 participants Est. completion 2020-10-28 53 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03987919

    A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 1879 participants Est. completion 2021-02-15 127 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04039503

    A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

    Not yet reported Eli Lilly and Company 475 participants Est. completion 2021-01-13 48 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04192292

    Study of Sulphonylurea Synergy With DPP4 Inhibitors

    Not yet reported University of Dundee 30 participants Est. completion 2020-12-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04228484

    The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2022-10-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04255433

    A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 13299 participants Est. completion 2025-06-12 635 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04537923

    A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin

    Not yet reported Eli Lilly and Company 1428 participants Est. completion 2022-11-01 135 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04610203

    Glycaemic Response, Insulinaemic Response, GLP-1 and GIP Testing of Food Product Lines

    Not yet reported Oxford Brookes University 41 participants Est. completion 2019-09-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04792762

    Physiology of GIP(1-30)NH2 in Humans

    Not yet reported University Hospital, Gentofte, Copenhagen 9 participants Est. completion 2019-06-09 1 site
    Other conditions: Glucose Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT04889859

    Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy

    Not yet reported Kyungpook National University Chilgok Hospital 30 participants Est. completion 2023-02-28 1 site
    Type 2 diabetes Other conditions: Stomach Neoplasm
    View official trial listing →
  • Completed NCT NCT05078255

    The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes

    Not yet reported Asger Lund, MD 61 participants Est. completion 2025-01-24 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05177653

    Separate and Combined Extrapancreatic Effects of the Incretin Hormones

    Not yet reported University Hospital, Gentofte, Copenhagen 13 participants Est. completion 2023-03-03 1 site
    Other conditions: Pancreatectomy; Hyperglycemia
    View official trial listing →
  • Status unknown NCT NCT05181150

    Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury

    Not yet reported University of Copenhagen 20 participants Est. completion 2024-11 1 site
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Completed NCT NCT05203237

    Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

    Not yet reported Viking Therapeutics, Inc. 92 participants Est. completion 2024-12-03 1 site
    MASH Other conditions: Weight Loss
    View official trial listing →
  • Completed NCT NCT05260021

    A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

    Not yet reported Eli Lilly and Company 99 participants Est. completion 2025-01-28 51 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Glucose Metabolism Disorders, Endocrine System Diseases, Metabolic Disease
    View official trial listing →
  • Completed NCT NCT05391581

    The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism

    Not yet reported University of Copenhagen 10 participants Est. completion 2023-02-07 1 site
    Other conditions: Blood Flow
    View official trial listing →
  • Status unknown NCT NCT05659368

    Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

    Not yet reported Ospedale San Raffaele 10 participants Est. completion 2024-12 1 site
    Other conditions: Wolfram Syndrome
    View official trial listing →
  • Status unknown NCT NCT05751720

    Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

    Not yet reported, Not yet reported Dr Adnan Agha 30 participants Est. completion 2025-02 1 site
    Type 2 diabetes Other conditions: Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Liver Fat
    View official trial listing →
  • Completed NCT NCT06137586

    The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes

    Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2024-05-17 1 site
    Other conditions: Type1diabetes, Hypoglycemia, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT06194955

    The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

    Not yet reported University of Copenhagen 50 participants Est. completion 2026-04-01 1 site
    Other conditions: Incretin Effect
    View official trial listing →
  • Enrolling by invitation NCT NCT06208904

    The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

    Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2025-12-31 1 site
    Other conditions: PostPrandial Hypotension
    View official trial listing →
  • Status unknown NCT NCT06368752

    The Role of Endogenous GIP in Glycosis Metabolism During Fasting

    Not yet reported Frederikke Koefoed-Hansen 12 participants Est. completion 2025-12-31 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06419686

    The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

    Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2024-07 1 site
    Other conditions: Effect of iv Administration of GIP and Alanine
    View official trial listing →
  • Completed NCT NCT06445075

    Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

    Not yet reported Scholar Rock, Inc. 102 participants Est. completion 2025-06-17 7 sites
    Other conditions: Overweight and Obesity
    View official trial listing →
  • Completed NCT NCT06564753

    Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

    Not yet reported Biomed Industries, Inc. 126 participants Est. completion 2025-04-18 5 sites
    Other conditions: Weight Loss, Obesity, Body Weight, Body Weight Changes
    View official trial listing →
  • Enrolling by invitation NCT NCT06581120

    GLP_1 RA Ultrasound Study

    Children's Hospital Medical Center, Cincinnati 100 participants Est. completion 2026-07 1 site
    Other conditions: Glucagon Like Peptide-1 (GLP-1, Delayed Gastric Emptying, Risk of Aspiration, Diabetes, Morbid Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT06801015

    Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

    Not yet reported Mayo Clinic 30 participants Est. completion 2028-03-31 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06881472

    The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes

    Not yet reported Asger Lund, MD 10 participants Est. completion 2026-01-16 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT06893211

    Effect of Tirzepatide on Brown Adipose Tissue in Obesity

    Not yet reported University Medical Centre Ljubljana 34 participants Est. completion 2025-12-20 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06895408

    Separate and Combined Extrapancreatic Effects of GIP and GLP-1

    Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2025-07-14 1 site
    Other conditions: Pancreatectomy; Hyperglycemia
    View official trial listing →
  • Completed NCT NCT07240246

    Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults

    Not yet reported FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation 40 participants Est. completion 2026-05-12 1 site
    Other conditions: GLP-1, Obesity &Amp; Overweight, Dietary Supplement
    View official trial listing →
  • Terminated NCT NCT07254988

    Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

    Not yet reported University of Copenhagen 3 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Spinal Muscular Atrophy (SMA), Cerebral Palsy (CP), Duchenne Muscular Dystrophy (DMD)
    View official trial listing →
  • Active, not recruiting NCT NCT07431086

    Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US

    Not yet reported Regeneron Pharmaceuticals 120 participants Est. completion 2026-12-18 3 sites
    Other conditions: Overweight or Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT07458269

    Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

    Not yet reported Kailera 264 participants Est. completion 2027-06 35 sites
    Other conditions: Obesity
    View official trial listing →
  • Enrolling by invitation NCT NCT07687589

    The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

    Not yet reported University of Copenhagen 14 participants Est. completion 2027-04-28 1 site
    Other conditions: Emesis
    View official trial listing →
  • Not yet recruiting NCT NCT07793929

    A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

    Not yet reported Kailera 32 participants Est. completion 2028-02-08 1 site
    Other conditions: End Stage Renal Disease, Renal Impairment, Obesity, Overweight
    View official trial listing →
  • Not yet recruiting NCT NCT07811895

    Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

    Not yet reported RenJi Hospital 1510 participants Est. completion 2030-12 1 site
    Other conditions: Tirzepatide, Frozen Embryo Transfer, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07812636

    Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer

    Not yet reported Milton S. Hershey Medical Center 15 participants Est. completion 2028-08-01 1 site
    Other conditions: Grade 1 Endometrial Endometrioid Carcinoma, Endometrial Intraepithelial Neoplasia, Metabolic Comorbidities
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: glucose dependent insulinotropic polypeptide, Glucose-dependent Insulinotropic Polypeptide (GIP)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.